Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- ASN Kidney Week 2025 Home Dialysis Sessions Posted 11-11-2025
- NKF and Vantive Launch a Home Dialysis Awareness and Education Campaign Posted 11-11-2025
- Vantive CONNECT is Powering a New Ecosystem Called HomeAdvantage Posted 11-11-2025
- AKF Free 1-day Dialysis at Home Event on November 20 at 11 AM ET Posted 10-14-2025

